Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
n°15 Viruses
Apparently the journal does not rank so bad...
check: https://www.scimagojr.com/journalrank.php?category=2406
https://simplywall.st/stocks/us/tech/nasdaq-apdn/applied-dna-sciences/news/applied-dna-sciences-inc-nasdaqapdn-is-expected-to-breakeven/
I don't know if there is much value in the article, but at least it addresses the breakeven point of APDN...
Best,
Pyriet
You're welcome. Enjoy your day's work!
IMO the following section is telling:
“We look forward to finishing the final follow-up visit, then unblinding and analyzing the full dataset from the study. Moreover, we remain optimistic that one day we will help address, in a substantial way, this area of considerable unmet medical need.”
news regarding APDN's DNA tagging implementation in fertilizer industry...
https://www.worldfertilizer.com/materials-handling/25092017/applied-dna-introduces-molecular-tag-to-fertilizer-industry/
New article on CTIX' UC/UPC trial results: https://www.insiderfinancial.com/markets-have-missed-an-opportunity-in-cellceutix-corp-otcmktsctix/120290/
new article on CTIX:
http://smallcapexclusive.com/dont-miss-rally-cellceutix-corp-otcmktsctix-shares/
Nothing new, but shows that we're building momentum...
Interesting article on the MRSA playing field + prices of the different treatments. And yes, Brilacidin gets mentioned as a potential first in class agent.
http://www.ptcommunity.com/journal/article/full/2016/2/126/companies-take-aim-mrsa-infections
Best,
Pyriet
FWIW, inspiring (kind of similar) law suit that got dropped...
http://finance.yahoo.com/news/galectin-therapeutics-announces-dismissals-federal-131500866.html
Orphan status-news is getting spread...
http://www.bostonherald.com/business/healthcare/2015/07/fda_gives_orphan_drug_status_to_beverly_biotech
Best,
Pyriet
Hi everybody.
I've been reading this message board for almost a year, without posting (mostly because I don't feel like I have the expertise to add something to the (often) very interesting discussions). But I just came across an interesting news item that may impact our B-OM story...
http://www.businesswire.com/news/home/20141030006368/en/Onxeo-S.A.-Positive-Phase-II-preliminary-results#.VFcTbPmG_Fc
Best.